Literature DB >> 29268359

Adjuvant chemotherapy following trimodality therapy for esophageal carcinoma-Is the evidence sufficient?

Scott M Atay1, Mariela Blum2, Boris Sepesi3.   

Abstract

Entities:  

Year:  2017        PMID： 29268359      PMCID： PMC5723781          DOI： 10.21037/jtd.2017.09.68

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

1.  Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer.

Authors:  Stephen G Swisher; Wayne Hofstetter; Ritsuko Komaki; Arlene M Correa; Jeremy Erasmus; Jeffrey H Lee; Zhongxing Liao; Dipen Maru; Reza Mehran; Shital Patel; David C Rice; Jack A Roth; Ara A Vaporciyan; Garrett L Walsh; Jaffer A Ajani
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

2.  Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

Authors:  Marc Ychou; Valérie Boige; Jean-Pierre Pignon; Thierry Conroy; Olivier Bouché; Gilles Lebreton; Muriel Ducourtieux; Laurent Bedenne; Jean-Michel Fabre; Bernard Saint-Aubert; Jean Genève; Philippe Lasser; Philippe Rougier
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

3.  Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.

Authors:  Kenneth L Meredith; Jill M Weber; Kiran K Turaga; Erin M Siegel; Jim McLoughlin; Sarah Hoffe; Melis Marcovalerio; Nilay Shah; Scott Kelley; Richard Karl
Journal:  Ann Surg Oncol       Date:  2010-02-06       Impact factor: 5.344

4.  A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).

Authors:  Nobutoshi Ando; Hoichi Kato; Hiroyasu Igaki; Masayuki Shinoda; Soji Ozawa; Hideaki Shimizu; Tsutomu Nakamura; Hiroshi Yabusaki; Norio Aoyama; Akira Kurita; Kenichiro Ikeda; Tatsuo Kanda; Toshimasa Tsujinaka; Kenichi Nakamura; Haruhiko Fukuda
Journal:  Ann Surg Oncol       Date:  2011-08-31       Impact factor: 5.344

5.  Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response?

Authors:  Robert A Meguid; Craig M Hooker; Joshua T Taylor; Laurence R Kleinberg; Stephen M Cattaneo; Marc S Sussman; Stephen C Yang; Richard F Heitmiller; Arlene A Forastiere; Malcolm V Brock
Journal:  J Thorac Cardiovasc Surg       Date:  2009-12       Impact factor: 5.209

6.  Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.

Authors:  T Glatz; P Bronsert; M Schäfer; B Kulemann; G Marjanovic; O Sick; U T Hopt; K Zirlik; F Makowiec; J Hoeppner
Journal:  Eur J Surg Oncol       Date:  2015-07-29       Impact factor: 4.424

7.  Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

Authors:  Nobutoshi Ando; Toshifumi Iizuka; Hiroko Ide; Kaoru Ishida; Masayuki Shinoda; Tadashi Nishimaki; Wataru Takiyama; Hiroshi Watanabe; Kaichi Isono; Norio Aoyama; Hiroyasu Makuuchi; Otsuo Tanaka; Hideaki Yamana; Shunji Ikeuchi; Toshiyuki Kabuto; Kagami Nagai; Yutaka Shimada; Yoshihide Kinjo; Haruhiko Fukuda
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

8.  Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Authors:  Austin M Dulak; Petar Stojanov; Shouyong Peng; Michael S Lawrence; Cameron Fox; Chip Stewart; Santhoshi Bandla; Yu Imamura; Steven E Schumacher; Erica Shefler; Aaron McKenna; Scott L Carter; Kristian Cibulskis; Andrey Sivachenko; Gordon Saksena; Douglas Voet; Alex H Ramos; Daniel Auclair; Kristin Thompson; Carrie Sougnez; Robert C Onofrio; Candace Guiducci; Rameen Beroukhim; Zhongren Zhou; Lin Lin; Jules Lin; Rishindra Reddy; Andrew Chang; Rodney Landrenau; Arjun Pennathur; Shuji Ogino; James D Luketich; Todd R Golub; Stacey B Gabriel; Eric S Lander; David G Beer; Tony E Godfrey; Gad Getz; Adam J Bass
Journal:  Nat Genet       Date:  2013-03-24       Impact factor: 38.330

9.  The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas.

Authors:  A Mirza; S Pritchard; I Welch
Journal:  Int J Surg Oncol       Date:  2013-09-17

10.  Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.

Authors:  John M Findlay; Francesc Castro-Giner; Seiko Makino; Emily Rayner; Christiana Kartsonaki; William Cross; Michal Kovac; Danny Ulahannan; Claire Palles; Richard S Gillies; Thomas P MacGregor; David Church; Nicholas D Maynard; Francesca Buffa; Jean-Baptiste Cazier; Trevor A Graham; Lai-Mun Wang; Ricky A Sharma; Mark Middleton; Ian Tomlinson
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919
View more
  2 in total

1.  Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction.

Authors:  Thomas W Rice; Min Lu; Hemant Ishwaran; Eugene H Blackstone
Journal:  J Thorac Oncol       Date:  2019-08-20       Impact factor: 15.609

2.  The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.

Authors:  Vignesh Raman; Oliver K Jawitz; Norma E Farrow; Soraya L Voigt; Kristen E Rhodin; Chi-Fu J Yang; Megan C Turner; Thomas A D'Amico; David H Harpole; Betty C Tong
Journal:  Ann Surg       Date:  2022-03-01       Impact factor: 13.787
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.